Stipend and Dates

Up to $12,960. Up to 2 screening Visits

Note: All dates and times are tentative and may change. Stage 1 Group 3
Day -1 Admit - 6:00am Sep 22, 2022 Thurs
*Day 10 - a payment within 10 business days after completion  
Day 20 Discharge - a payment within 10 business days after completion Oct 12, 2022 Wed
Day 27 Outpatient Visit - a payment within 10 business days completion Oct 19, 2022 Wed


Click here to make an appointment for IP 0299-0098 Stage 1

Or call 210-225-5437 for more information


Study Criteria

Healthy Males – Non-Smoking

Age:  25-55

BMI:  >/18- to 30 kg/m2    Weight: at least 110 pounds

GFR: greater than 90 mL/min


Study Information

Indication: The investigational drug is being developed as a possible treatment of Parkinson’s disease.

Route of Administration: Oral

Washout from previous study: Receipt of an investigational drug within 30 days before dosing.

Males who are sexually active and whose partners are females of childbearing potential must refrain from donating sperm for at least 90 Days, agree to remain abstinent or must use condoms for the duration of the study and for 90 days following last study dose and their partners must be willing to use a highly effective method of contraception.


Study Reminders

  • 4 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment (including prescription, over the counter, herbal supplements and vitamins)
  • Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a valid government issued identification card such as a driver's license, state issued ID card or passport.  You will be required to show this same photo ID at all study visits
  • Arrive 30 minutes before your appointment to complete paper work.
IP 0299-0098 Stage 1
Healthy Males
Not Currently Screening.
Payment amount
Up to $12,960
25 - 55